Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2004

01-04-2004 | Case Report

Clinical Response of Antilymphocyte Globulin-Based Treatment in Patients in Taiwan with Aplastic Anemia: Positive Hepatitis C Antibody May Represent a Response Predictor

Authors: Yin-Hsun Feng, Chia-Jui Yen, Wen-Tsung Huang, Wu-Chou Su, Tsai-Yun Chen, Chao-Jung Tsao

Published in: International Journal of Hematology | Issue 2/2004

Login to get access
Metadata
Title
Clinical Response of Antilymphocyte Globulin-Based Treatment in Patients in Taiwan with Aplastic Anemia: Positive Hepatitis C Antibody May Represent a Response Predictor
Authors
Yin-Hsun Feng
Chia-Jui Yen
Wen-Tsung Huang
Wu-Chou Su
Tsai-Yun Chen
Chao-Jung Tsao
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 2/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.A10306

Other articles of this Issue 2/2004

International Journal of Hematology 2/2004 Go to the issue

OriginalPaper

Membranous nephropathy after allogeneic stem cell transplantation: meport of 2 cases

Case Report

Successful unrelated donor bone marrow transplantation for shwachman-diamond syndrome with leukemia

Case Report

Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells

Letter

Paralytic ileus occurring during treatment with all-trans retinoic acid for acute promyelocytic leukemia

Report

The fifth nagoya international blood and marrow transplantation symposium: unlimited possibilities of hematopoietic cell transplantation: lessons from the past and prospects for the future

Case Report

Primary adult T-Cell leukemia/lymphoma of bone
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits